Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hervé Avet-Loiseau

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Best Practice & Research. Clinical Haematology|December 12, 2007
Role of genetics in prognostication in myelomaHervé Avet-Loiseau
Hematology. American Society of Hematology. Education Program|January 18, 2011
Ultra high-risk myelomaHervé Avet-Loiseau
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Risk-Based Therapeutic StrategiesJill Corre, Hervé Avet-Loiseau
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
The impact of genomics on the management of myelomaJill Corre, Hervé Avet-Loiseau
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Genomics in multiple myelomaNikhil C Munshi, Hervé Avet-Loiseau
Blood|January 29, 2015
Genetics of multiple myeloma: another heterogeneity level?Jill Corre, Nikhil Munshi, Hervé Avet-Loiseau
Presse Medicale (Paris, France : 1983)|May 19, 2007
[Malignant transformation of monoclonal gammopathy of undetermined significance]Olivier Decaux, Hervé Avet-Loiseau, Bernard Grosbois
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Risk Stratification and Targets in Multiple Myeloma: From Genomics to the BedsideAurore Perrot, Jill Corre, Hervé Avet-Loiseau
Blood|July 29, 2021
Requirements for operational cure in multiple myelomaMohamad Mohty, Hervé Avet-Loiseau, Jean-Luc Harousseau
Blood|October 7, 2020
Risk factors in multiple myeloma: is it time for a revision?Jill Corre, Nikhil C Munshi, Hervé Avet-Loiseau
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Best Practice & Research. Clinical Haematology|December 12, 2007
Role of genetics in prognostication in myelomaHervé Avet-Loiseau
Hematology. American Society of Hematology. Education Program|January 18, 2011
Ultra high-risk myelomaHervé Avet-Loiseau
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Risk-Based Therapeutic StrategiesJill Corre, Hervé Avet-Loiseau
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
The impact of genomics on the management of myelomaJill Corre, Hervé Avet-Loiseau
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Genomics in multiple myelomaNikhil C Munshi, Hervé Avet-Loiseau
Blood|January 29, 2015
Genetics of multiple myeloma: another heterogeneity level?Jill Corre, Nikhil Munshi, Hervé Avet-Loiseau
Presse Medicale (Paris, France : 1983)|May 19, 2007
[Malignant transformation of monoclonal gammopathy of undetermined significance]Olivier Decaux, Hervé Avet-Loiseau, Bernard Grosbois
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Risk Stratification and Targets in Multiple Myeloma: From Genomics to the BedsideAurore Perrot, Jill Corre, Hervé Avet-Loiseau
Blood|July 29, 2021
Requirements for operational cure in multiple myelomaMohamad Mohty, Hervé Avet-Loiseau, Jean-Luc Harousseau
Blood|October 7, 2020
Risk factors in multiple myeloma: is it time for a revision?Jill Corre, Nikhil C Munshi, Hervé Avet-Loiseau
Pageof 20